Latest news on Alzheimer's

After five years of research and the participation of around one hundred volunteers, the PENSA study concludes with a closing gathering to share the study’s results with the participants.

The two selected projects aim to promote innovative approaches to the prevention and treatment of Alzheimer's disease.

50 people joined this satellite event with the aim of aligning clinical practice and research on amyloid, FDG and tau PET in the era of disease-modifying therapies.

During the open day, we brought Alzheimer’s research closer to more than a thousand people with a hands-on workshop and a talk on prevention and healthy lifestyle habits.

The European Researchers’ Night is held every year on the last Friday of September in more than 300 cities across 30 European countries

Following the positive opinion from the EMA in July, the European Commission has now authorized the marketing of the drug.

The international study shows that this biomarker allows detection of the presence of amyloid beta deposits, a key pathology in the development of the disease, in individuals without cognitive impairment

This year the Foundation highlights the role of the caregiver, warn about the lack of institutional support and emphasise research as the only way to find a solution to the disease

A clinical trial conducted jointly by the Research Institute of Hospital del Mar and the Barcelonaβeta Brain Research Center, concludes that combining a healthy lifestyle program with epigallocatechin gallate (EGCG), a natural compound found in green tea, could offer sustained cognitive benefits in people at high risk of developing Alzheimer’s dise